Palliative care concepts in respiratory disease

Respiration

Volumn 82, Issue 6, 2011, Pages 483-491

  Heigener, D F ^a   Rabe, K F ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Dispnea; Palliative care; Respiratory disease

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ANAMORELIN; CANNABIS; CODEINE; COLONY STIMULATING FACTOR; DEXTROMETHORPHAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FENTANYL; GHRELIN; INDOMETACIN; IPRATROPIUM BROMIDE; LIDOCAINE; MEGESTROL ACETATE; METHYLPHENIDATE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MIRTAZAPINE; MORPHINE; OPIATE; PREDNISOLONE; TETRAHYDROCANNABINOL;

ANOREXIA; ARTIFICIAL VENTILATION; BEHAVIOR THERAPY; BLOOD TRANSFUSION; CACHEXIA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COUGHING; CYSTIC FIBROSIS; DROWSINESS; DYSPNEA; EXERCISE; FATIGUE; HUMAN; LONG TERM CARE; LUNG CANCER; NERVOUSNESS; NOSE IRRITATION; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT COUNSELING; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; POSTURAL DRAINAGE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESPIRATORY CARE; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; WALKING AID;

DYSPNEA; HEALTH SERVICES ACCESSIBILITY; HUMANS; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; WALKERS;

EID: 82255192976     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000334189     Document Type: Review

References (59)

1. Edmonds P, Karlsen S, Khan S, Addington- Hall J: A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001; 15: 287-295. (Pubitemid 32640547)
2. Lynn J, Ely EW, Zhong Z, McNiff KL, Dawson NV, Connors A, Desbiens NA, Claessens M, McCarthy EP: Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000; 48:S91-S100. (Pubitemid 30266001)
3. Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N, Manegold C: Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 2009; 27: 1227-1234.
4. Gore JM, Brophy CJ, Greenstone MA: How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55: 1000-1006.
5. Scano G, Stendardi L, Grazzini M: Understanding dyspnoea by its language. Eur Respir J 2005; 25: 380-385. (Pubitemid 40246542)
6. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S: Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010; 39: 831-838.
7. Bausewein C, Booth S, Gysels M, Higginson I: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008;CD005623.
8. Schucher B, Magnussen H: Mechanical ventilation in chronic ventilatory insufficiency. Pneumologie 2007; 61: 644-652.
9. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report. Chest 1999; 116: 521-534.
10. Marciniuk D, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, Mularski RA, Cave AJ, Mayers I, Kennedy V, Oliver TK, Brown C: Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J 2011; 18: 69-78.
11. Casaburi R, ZuWallack R: Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 1329-1335.
12. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R: Exercise training decreases ventilatory requirements and exercise- induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128: 2025-2034. (Pubitemid 41507537)
13. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. Ann Intern Med 1980; 93: 391-398.
14. Medical Research Council Working Party: Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;i:681-686.
15. Strom K, Boman G: Long-term oxygen therapy in parenchymal lung diseases: An analysis of survival. The Swedish Society of Chest Medicine. Eur Respir J 1993; 6: 1264-1270. (Pubitemid 23329540)
16. Magnussen H, Kirsten AM, Kohler D, Morr H, Sitter H, Worth H: Guidelines for long - term oxygen therapy. German Society for Pneumology and Respiratory Medicine. Pneumologie 2008; 62: 748-756.
17. Górecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J: Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52:674-679. (Pubitemid 27404979)
18. Fletcher EC, Levin DC: Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen. Chest 1984;85:6-14. (Pubitemid 14215293)
19. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos Santos J: A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999;14:1002-1008.
20. Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, Young IH, Bull J, Wilcock A, Booth S, Wheeler JL, Tulsky JA, Crockett AJ, Currow DC: Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: A double-blind, randomised controlled trial. Lancet 2010; 376: 784-793.
21. Young IH, Daviskas E, Keena VA: Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. Thorax 1989; 44: 387-390. (Pubitemid 19143946)
22. Chan KS, Sham MK, Tse DM, Thorsen AB: Palliative medicine in malignant respiratory diseases; in Doyle D, Hanks G, Cherny N, Calman K (eds): Oxford Textbook of Palliative Medicine. Oxford, Oxford University Press, 2005.
23. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE: A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939-944. (Pubitemid 35316271)
24. Man GC, Hsu K, Sproule BJ: Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 1986; 90: 832-836. (Pubitemid 17196171)
25. Stark RD, Gambles SA, Lewis JA: Methods to assess breathlessness in healthy subjects: A critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 1981; 61: 429-439. (Pubitemid 12243008)
26. Dobbertin I, Dierkesmann R, Kwiatkowski J, Reichardt W: Bronchoscopic aspects of renal cell carcinoma (RCC). Anticancer Res 1999; 19: 1567-1572. (Pubitemid 29255649)
27. Leach RM: Palliative medicine and non-malignant, end-stage respiratory disease; in Doyle D, Hanks G, Cherny N, Calman K (eds): Textbook of Palliative Medicine. Oxford, Oxford University Press, 2005, pp 895- 916.
28. Kirilloff LH, Owens GR, Rogers RM, Mazzocco MC: Does chest physical therapy work? Chest 1985; 88: 436-444. (Pubitemid 15248108)
29. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O'Byrne P, Poe RH, Prakash UB, Pratter MR, Rubin BK: Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114: 133S-181S.
30. Christensen HR, Simonsen K, Lange P, Clementsen P, Kampmann JP, Viskum K, Heideby J, Koch U: PEEP-masks in patients with severe obstructive pulmonary disease: A negative report. Eur Respir J 1990; 3: 267-272. (Pubitemid 20128545)
31. Christensen EF, Nedergaard T, Dahl R: Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy. Chest 1990; 97: 645-650. (Pubitemid 20095585)
32. Thomas J, Cook DJ, Brooks D: Chest physical therapy management of patients with cystic fibrosis. A meta-analysis. Am J Respir Crit Care Med 1995; 151: 846-850.
33. Rogers DF: Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007; 52: 1176-1193.
34. Matthys H, Bleicher B, Bleicher U: Dextromethorphan and codeine: Objective assessment of antitussive activity in patients with chronic cough. J Int Med Res 1983; 11: 92-100. (Pubitemid 13118502)
35. Aylward M, Maddock J, Davies DE, Protheroe DA, Leideman T: Dextromethorphan and codeine: Comparison of plasma kinetics and antitussive effects. Eur J Respir Dis 1984; 65: 283-291. (Pubitemid 14131571)
36. Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, Thompson R: Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007; 175: 312-315.
37. Molassiotis A, Smith JA, Bennett MI, Blackhall F, Taylor D, Zavery B, Harle A, Booton R, Rankin EM, Lloyd-Williams M, Morice AH: Clinical expert guidelines for the management of cough in lung cancer: Report of a UK task group on cough. Cough 2010; 6: 9.
38. Evald T, Munch EP, Kok-Jensen A: Chronic non-asthmatic cough is not affected by inhaled beclomethasone dipropionate. A controlled double blind clinical trial. Allergy 1989; 44: 510-514.
39. Holmes PW, Barter CE, Pierce RJ: Chronic persistent cough: Use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med 1992; 86: 425-429.
40. Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K: Management of cancer-related fatigue. Cancer Invest 2005; 23: 229-239. (Pubitemid 40770741)
41. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE: The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain Behav Immun 2007; 21: 413-427. (Pubitemid 46528677)
42. White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, Bavinton J, Angus BJ, Murphy G, Murphy M, O'Dowd H, Wilks D, McCrone P, Chalder T, Sharpe M: Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial. Lancet 2011; 377: 823-836.
43. Pirraglia PA, Casserly B, Velasco R, Borgia ML, Nici L: Association of change in depression and anxiety symptoms with functional outcomes in pulmonary rehabilitation patients. J Psychosom Res 2011; 71: 45-49.
44. Brown E, Hurlow A, Rahman A, Closs SJ, Bennett MI: Assessment of fatigue after blood transfusion in palliative care patients: A feasibility study. J Palliat Med 2010; 13: 1327-1330.
45. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR: American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010; 28: 4996-5010.
46. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL: Phase III, randomized, doubleblind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 2010; 28: 3673-3679.
47. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P: A systematic review and metaanalysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008; 100: 1155-1166.
48. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
49. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
50. Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF: Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100: 1349-1355. (Pubitemid 43942332)
51. Farber MO, Mannix ET: Tissue wasting in patients with chronic obstructive pulmonary disease. Neurol Clin 2000; 18: 245-262.
52. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG: Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-966. (Pubitemid 26081646)
53. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, Macdonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE: Definition and classification of cancer cachexia: An international consensus. Lancet Oncol 2011; 12: 489-495.
54. Budweiser S, Heinemann F, Meyer K, Wild PJ, Pfeifer M: Weight gain in cachectic COPD patients receiving noninvasive positivepressure ventilation. Respir Care 2006; 51: 126-132. (Pubitemid 46888410)
55. Garcia JM, Polvino WJ: Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res 2009; 19: 267-273.
56. Lesniak W, Bala M, Jaeschke R, Krzakowski M: Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome - a systematic review and meta-analysis. Pol Arch Med Wewn 2008; 118: 636-644.
57. Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T: Comparison of orally administered cannabis extract and delta-9- tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia- Study- Group. J Clin Oncol 2006; 24: 3394-3400. (Pubitemid 46638895)
58. Riechelmann RP, Burman D, Tannock IF, Rodin G, Zimmermann C: Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am J Hosp Palliat Care 2010; 27: 106-110.
59. Lundholm K, Gelin J, Hyltander A, Lonnroth C, Sandstrom R, Svaninger G, Korner U, Gulich M, Karrefors I, Norli B: Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54: 5602-5606. (Pubitemid 24346254)